Alcohol inflammation and coronary heart disease

Addiction Biology

Volumn 8, Issue 3, 2003, Pages 271-277

  Imhof, Armin ^a   Koenig, Wolfgang ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALCOHOL; AMYLOID A PROTEIN; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; SELECTIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; CARDIOVASCULAR SYMPTOM; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; DOSE RESPONSE; GENETIC ASSOCIATION; HEART PROTECTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; PRIORITY JOURNAL; REVIEW;

ALCOHOL DRINKING; ALCOHOLISM; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; CHOLESTEROL, HDL; CORONARY DISEASE; CYTOKINES; ETHANOL; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; TEMPERANCE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0141705368     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210310001602176     Document Type: Review

References (66)

1. Fagrell B, De Faire U, Bondy S et al. The effects of light to moderate drinking on cardiovascular diseases. J Intern Med 1999;246:331-40.
2. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev 1993;15:328-51.
3. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000;95:1505-23.
4. Rimm EB, Stampfer MJ. Wine, beer, and spirits: are they really horses of a different color? Circulation 2002;105:2806-7.
5. Kanagasundaram N, Leevy CM. Ethanol, immune reactions and the digestive system. Clin Gastroenterol 1981;10:295-306.
6. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001;357:763-7.
7. MacGregor RR, Louria DB. Alcohol and infection. Curr Clin Top Infect Dis 1997;17:291-315.
8. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system - a review. Alcohol Clin Exp Res 1998;22:1927-42.
9. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis 1999;19:205-19.
10. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76.
11. Diaz LE, Montero A, Gonzalez-Gross M, Vallejo AI, Romeo J, Marcos A. Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002;56(Suppl 3):S50-3.
12. Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999;34:830-41.
13. Nelson S, Kolls JK. Alcohol, host defence and society. Nat Rev Immunol 2002;2:205-9.
14. Poikolainen K. It can be bad for the heart, too - drinking patterns and coronary heart disease. Addiction 1998;93:1757-9.
15. Mukamal KJ, Conigrave KM, Mittleman MA et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003;348:109-18.
16. Gruchow HW, Hoffmann RG, Anderson AJ, Barboriak JJ. Effects of drinking patterns on the relationship between alcohol an coronary occlusion. Atherosclerosis 1982;43:393-404.
17. Kauhanen J, Kaplan GA, Goldberg DE, Salonen JT. Beer binging and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. Br Med J 1997;315:846-51.
18. White IR. The level of alcohol consumption at which all-cause mortality is least. J Clin Epidemiol 1999;52:967-75.
19. Rehm J, Sempos CT, Trevisan M. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease - a review. J Cardiovasc Risk 2003;10:15-20.
20. Bell JR, Donovan JL, Wong R et al. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr 2000;71:103-8.
21. Gronbaek M, Becker U, Johansen D et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000;133:411-19.
22. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
23. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836-44.
24. Brenner H, Rothenbacher D, Bode G, Marz W, Hoffmeister A, Koenig W. Coronary heart disease risk reduction in a predominantly beer-drinking population. Epidemiology 2001;12:390-5.
25. Gaziano JM, Hennekens CH, Godfried SL et al. Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol 1999;83:52-7.
26. Hines LM, Stampfer MJ, Ma J et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001;344:549-55.
27. Klatzky A. Should patients with heart disease drink alcohol? JAMA 2001;285:2004-6.
28. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910-15.
29. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J 1999;319:1523-8.
30. Mukamal KJ, Jadhav PP, D'Agostino RB et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001;104:1367-73.
31. Mennen LI, Balkau B, Vol S, Caces E, Eschwege E. Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 1999;19:887-92.
32. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
33. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281-91.
34. Rosenson RS, Koenig W. High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Curr Opin Cardiol 2002;17:325-31.
35. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001;89:763-71.
36. Danesh J, Whincup P, Walker M et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 2000;321:199-204.
37. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003;107:443-7.
38. Nakanishi N, Yoshida H, Okamoto M, Matsuo Y, Suzuki K, Tatara K. Association of alcohol consumption with white blood cell count: a study of Japanese male office workers. J Intern Med 2003;253:367-74.
39. Sierksma A, Van Der Gaag MS, Kluft C, Hendriks HF. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 2002;56:1130-6.
40. Napoli C, D'Armiento FP, Mancini FP et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-90.
41. Skalen K, Gustafsson M, Rydberg EK et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002;417:750-4.
42. Witztum JL, Berliner JA. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 1998;9:441-8.
43. Rajavashisth TB, Andalibi A, Territo MC et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 1990;344:254-7.
44. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
45. Wang J, Sica A, Peri G et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1166-74.
46. Cybulsky MI, Iiyama K, Li H et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-62.
47. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998;102:145-52.
48. Gu L, Okada Y, Clinton SK et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-81.
49. Gosling J, Slaymaker S, Gu L et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999;103:773-8.
50. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
51. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195:245-57.
52. Nelson S, Bagby GJ, Bainton BG, Summer WR. The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. J Infect Dis 1989;160:422-9.
53. Kolls JK, Xie J, Lei D, Greenberg S, Summer WR, Nelson S. Differential effects of in vivo ethanol on LPS-induced TNF and nitric oxide production in the lung. Am J Physiol 1995;268:L991-8.
54. Szabo G, Mandrekar P, Catalano D. Inhibition of superantlgen-induced T cell proliferation and monocyte IL-1 beta, TNF-alpha, and IL-6 production by acute ethanol treatment. J Leukoc Biol 1995;58:342-50.
55. Verma BK, Fogarasi M, Szabo G. Down-regulation of tumor necrosis factor alpha activity by acute ethanol treatment in human peripheral blood monocytes. J Clin Immunol 1993;13:8-22.
56. Frostegard J, Ulfgren AK, Nyberg P et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;145:33-43.
57. Mach F, Schonbeck U, Sukhova GK et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997;94:1931-6.
58. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
59. Torzewski J, Torzewski M, Bowyer DE et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-92.
60. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7.
61. Mandrekar P, Catalano D, Szabo G. Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes. Int Immunol 1999;11:1781-90.
62. Blanco-Colio LM, Valderrama M, Alvarez-Sala LA et al. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 2000;102:1020-6.
63. Szabo G, Verma BK, Fogarasi M, Catalano DE. Induction of transforming growth factor-beta and prostaglandin E2 production by ethanol in human monocytes. J Leukoc Biol 1992;52:602-10.
64. de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4 + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
65. Mandrekar P, Catalano D, Girouard L, Szabo G. Human monocyte IL-10 production is increased by acute ethanol treatment. Cytokine 1996;8:567-77.
66. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.